Hutch News
Results per Page:
Cancer care: From ‘sledgehammer’ to precision cellular therapy
AACR progress report: new immunotherapies improve outcomes, but access to care and clinical trials for many still lags
New study of Asian, Native Hawaiian and Pacific Islander populations gets $38.7M grant
Fred Hutch will act as coordinating center for large study of cardiovascular and other chronic diseases in overlooked populations
Pre-transplant microbiome sets the stage for GVHD
Preclinical findings highlight bacterial groups that influence GVHD risk
Computational method identifies genetic drivers of microbiome diversity
From the Wu Group, Public Health Sciences Division
Untangling how body location promotes cancer
Beronja Lab postdoc Rachel Lex receives ACS fellowship to uncover regional factors driving tumor development
Is the microbiome a springboard or barrier to effective vaccination?
From the Kublin Lab, Vaccine and Infectious Disease Division
Bugs, drugs, and cancer: potential links between tumor microbes and cancer treatment
From the Bullman Lab, Human Biology Division
How to “ConQuR” batch effects in microbiome data
From the Wu and Randolph Labs, Biostatistics and Computational Biology Program, Cancer Consortium.
Year in Pictures: 2022
A look back at the year through compelling images
How bacteria give cancer a helping hand
Two new studies show how bugs could help tumors progress and resist treatment
The gut factor: associations between the microbiome and Ace2 expression
From the Dey Lab, Clinical Research Division
Omics made easier
To see the big picture, just add ‘ome’
Studying how maternal immune factors shape infant health
Immunologist Dr. Megan Koch named 2020 Pew Scholar in the Biomedical Sciences
Immune response in colorectal cancer: What helps, what hurts?
GECCO collaboration drills into mechanisms of specific T-cell response to germline variations, lifetime exposures and tumor environment
Integrative oncology program opens at SCCA
Research and rigor will guide integrative therapies that help cancer patients tolerate standard treatment
Fred Hutch deepens its focus on the microbiome
Microbiome Research Initiative hosts 2-day symposium